Selected article for: "antimalarial chloroquine and hydroxychloroquine antimalarial chloroquine"

Author: dos Reis Neto, Edgard Torres; Kakehasi, Adriana Maria; de Medeiros Pinheiro, Marcelo; Ferreira, Gilda Aparecida; Marques, Cláudia Diniz Lopes; da Mota, Licia Maria Henrique; dos Santos Paiva, Eduardo; Pileggi, Gecilmara Cristina Salviato; Sato, Emília Inoue; Reis, Ana Paula Monteiro Gomides; Xavier, Ricardo Machado; Provenza, José Roberto
Title: Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
  • Cord-id: 3k48ci7b
  • Document date: 2020_6_9
  • ID: 3k48ci7b
    Snippet: Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-mediated inflammatory rheumatic diseases for decades. It is an appropriate time to review their immunomodulatory and anti-inflammatory mechanisms impact on disease activity and survival of systemic lu
    Document: Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-mediated inflammatory rheumatic diseases for decades. It is an appropriate time to review their immunomodulatory and anti-inflammatory mechanisms impact on disease activity and survival of systemic lupus erythematosus patient, including antiplatelet effect, metabolic and lipid benefits. We also discuss possible adverse effects, adding a practical and comprehensive approach to monitoring rheumatic patients during treatment with these drugs.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and activate platelet: 1
    • abdominal pain and additional test: 1
    • abdominal pain and liver failure: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and long short: 1, 2, 3, 4
    • abdominal pain and long short term: 1, 2, 3, 4, 5
    • abdominal pain and long term survival: 1, 2
    • abdominal pain and low density: 1, 2
    • abdominal pain and lupus erythematosus: 1, 2, 3, 4
    • abdominal pain and lupus nephritis: 1
    • abdominal pain and lupus patient: 1, 2, 3
    • abdominal pain and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abdominal pain and magnetic resonance imaging: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14